Brief: Longeveron Announces Completion Of Enrollment In Phase 2A Trial Of Lomecel-B For Treatment Of Alzheimer's Disease
10/11/2022 14:44
Nov 10 (Reuters) - Longeveron Inc LGVN.O :
* LONGEVERON ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2A
TRIAL
OF LOMECEL-B™ FOR THE TREATMENT OF ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNX5g6vZx
Further company coverage: LGVN.O
((reuters.briefs@thomsonreuters.com;))